アスピリンは,血小板TXA2のT細胞免疫抑制を制限することによって転移を防ぐ
Jie Yang1, Yumi Yamashita-Kanemaru2, Benjamin I Morris2
1Department of Pathology, University of Cambridge, Cambridge, UK. jy437@cam.ac.uk.
Nature
|March 5, 2025
まとめ
アスピリンと他のサイクロオキシゲネーゼ- 1 (COX- 1) 阻害剤は,血小板由来トロンボキサンA2 (TXA2) がT細胞を抑制することを阻害することによって,抗癌免疫を強化します. このメカニズムは 癌の転移に対する免疫療法を改善する 新しい経路を示しています
科学分野:
- 免疫学
- 腫瘍学
- 薬理学について
背景:
- 転移は90%の癌の死亡の原因で 転移する細胞は免疫攻撃に脆弱です
- 治療戦略は この脆弱性を利用して がんの再発を防ぐことを目的としています
研究 の 目的:
- アスピリンのようなサイクロオキシゲネーゼ-1 (COX-1) 阻害剤が抗がん免疫にどのように影響するかを調査する.
- 血小板由来トロンボキサンA2 (TXA2) が転移に対するT細胞反応を抑制するメカニズムを解明する.
主な方法:
- T細胞特異的なArhgef1の削除を伴うマウスモデルを使用した.
- アスピリンと選択的COX-1阻害剤を投与し,血小板特異的なCOX-1デレーションを行いました.
- T細胞の活性化,シグナル伝達経路,転移率を in vivo で評価した.
主要な成果:
- COX-1 阻害剤はTXA2媒介による抑制からT細胞を放出する.
- ARHGEF1によるTXA2シグナル伝達は,T細胞受容体シグナル伝達,増殖,およびエフェクター機能を阻害する.
- TXA2の可用性の低下は,T細胞に依存した方法で転移率を低下させた.
結論:
- T細胞におけるTXA2とARHGEF1を含む新しい免疫抑制経路が特定され,抗転移免疫を制限する.
- アスピリンの抗転移効果は,T細胞の免疫強化によって示されている.
- この発見は,この経路を標的とした新しい抗転移性免疫療法の開発を支持する.
さらに関連する動画
関連する概念動画
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
454
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
454
Formation of the Platelet Plug
3.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
590
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
590
Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K


